Suit H D
Radiology. 1977 May;123(2):483-7. doi: 10.1148/123.2.483.
TCD50 values for thermally resistant tumors have been significantly reduced. The therapeutic ratio has been improved for some tumor-normal tissue situations and treatment protocols, but not for others. The oxygen enhancement ratio (OER) for hyperthermic damage may be congruent to 1; if this is true for tumor cells in vivo, the combination of hyperthermia and radiation should improve the therapeutic ratio to the extent that hypoxic cells are critical. There does not appear to be a differential response to hyperthermia by the normal foot or tumor growing in the foot pad for the following two parameters: (a) relationship between heating time to produce the specified response and the level of heating, and (b) effect of fractionation of hyperthermia.
耐热肿瘤的半数致死温度(TCD50)值已显著降低。对于某些肿瘤-正常组织情况和治疗方案,治疗比有所提高,但并非所有情况都是如此。热损伤的氧增强比(OER)可能等于1;如果体内肿瘤细胞确实如此,那么热疗与放疗联合应用应能在缺氧细胞起关键作用的程度上提高治疗比。对于以下两个参数,正常足部或足部垫内生长的肿瘤对热疗似乎没有差异反应:(a)产生特定反应的加热时间与加热水平之间的关系,以及(b)热疗分次治疗的效果。